4//SEC Filing
Galson Steven K 4
Accession 0001127602-21-024770
CIK 0000882796other
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 4:25 PM ET
Size
5.2 KB
Accession
0001127602-21-024770
Insider Transaction Report
Form 4
Galson Steven K
Director
Transactions
- Award
Non-Qualified Stock Option
2021-09-01+60,000→ 60,000 totalExercise: $16.15Exp: 2031-09-01→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Amended and Restated Stock Incentive Plan.
- [F2]The option vests 1/36 per month for a period of 36 months, beginning on October 1, 2021.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001495328
Filing Metadata
- Form type
- 4
- Filed
- Sep 1, 8:00 PM ET
- Accepted
- Sep 2, 4:25 PM ET
- Size
- 5.2 KB